文献速递骨肿瘤关节外科

髋臼笼与骨水泥固定治疗破坏性髋臼转移瘤是否足够持久?

Is an Acetabular Cage and Cement Fixation Sufficiently Durable for the Treatment of Destructive Acetabular Metastases?
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

本研究回顾了2006至2017年间采用髋臼部分骨盆笼联合骨水泥全髋置换治疗的47髋(46例)破坏性髋臼转移瘤患者,2年和4年再手术或翻修累积发生率分别为8%和16%,仅1例出现笼松动但未翻修,作者认为该方案足够持久可继续使用,但需对比研究确定优劣。

要点

  • 47髋(46例)髋臼转移瘤采用髋臼笼联合骨水泥全髋置换,2年再手术或翻修累积发生率8%(95%CI 3.6-12.6),4年16%(95%CI 9.2-23.2)。
  • 仅1例术后8年因局部疾病进展出现笼松动并观察处理,无患者因髋臼固定丢失而翻修。
  • 术后4例脱位(其中3例再手术)、1例深部感染再手术、1例术后30天内死亡;仅1例未能社区行走。

核心结论

  • 作者认为在这一小样本系列中该方案足够持久,可继续用于髋臼转移瘤伴塌陷或对非手术治疗无反应的患者,但需要对比研究来确定其优于还是劣于其他可选方案。

研究设计与样本

  • 回顾性分析2006年至2017年连续治疗的47髋(46例)髋臼转移瘤患者,均采用髋臼部分骨盆笼联合骨水泥全髋置换,常规随访在3个月和12个月。
  • 46例中17例(37%)在1年内死亡,其余患者随访超过1年;仅1例存活患者过去5年未随访。
  • 采用竞争风险分析计算无再手术或翻修的假体生存率,未评估患者报告结局,通过病历回顾获取社区行走能力及辅助器具使用情况。

主要发现

  • 1例术后8年因局部疾病进展出现笼松动并观察处理,无患者因髋臼固定丢失而翻修。
  • 再手术或翻修累积发生率2年为8%(95%CI 3.6-12.6),4年为16%(95%CI 9.2-23.2)。
  • 术后4例脱位,其中3例再手术;1例深部感染再手术;1例术后30天内死亡。
  • 术后仅1例未能在社区行走,23例独立行走,10例使用手杖,12例使用助行器。

临床怎么用

  • 作者认为该方案足够持久,可继续用于髋臼转移瘤伴塌陷或对放疗和镇痛等非手术治疗无反应的患者。
  • 作者指出需要对比研究来确定该方案优于还是劣于其他可选方案。

局限性

  • 作者指出本文为小样本系列(small series)。
  • 作者指出需要对比研究来确定该方案优于还是劣于其他可选方案。
  • 作者未评估患者报告结局,行走能力数据通过病历回顾获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Destructive bony acetabular metastases cause pain, pathological fractures, and loss of mobility. Although multiple fixation options are available, we have favored a rigid stainless steel partial pelvic cage for acetabular fixation in these patients; however, little is known about the durability of this approach. QUESTION/PURPOSES: (1) How common was loss of fixation in a small series of metastatic acetabular defects treated with an acetabular cage and cemented total hip replacement? (2) What is the implant survival free from reoperation or revision at 2 and 4 years using a competing-risks survivorship estimator in patients thus treated? (3) What complications were associated with the treatment? (4) What level of postoperative mobility was achieved? METHODS: Between 2006 and 2017, we treated all acetabular metastases that needed surgical intervention, not amenable to conventional cemented THA alone with our single technique of acetabular partial pelvic cage and cemented total hip replacement. We treated 47 hips in 46 patients whose acetabular metastasis led to acetabular collapse or who were unresponsive to nonoperative measures of radiation therapy and analgesia. Routine followup occurred at 3 and 12 months; 17 of 46 patients (37%) died before 1 year, and all other patients were followed beyond 1 year. Only one patient who remains alive has not been seen in the past 5 years. Loss of fixation was determined by radiological or clinical signs of cage loosening. Survivorship free from reoperation or revision at 2 and 4 years was determined using competing-risks analysis. We did not assess patient-reported outcomes, but we did have data on the proportion of patients who were able to ambulate in the community and if so, what assistive devices they used, which we obtained by chart review. RESULTS: One patient experienced cage loosening identified 8 years postoperatively as a result of local disease progression and has been managed with observation. No patients underwent revision for loss of acetabular fixation. The cumulative incidence of reoperation or revision was 8% at 2 years (95% CI, 3.6-12.6) and 16% at 4 years (95% CI, 9.2-23.2). Four patients had postoperative dislocations, of which three underwent reoperation. One patient developed a postoperative deep infection and underwent reoperation. One patient died within 30 days of surgery. Only one patient did not ambulate in the community postoperatively; 23 ambulated independently, 10 with the use of a walking stick and 12 using a walker. CONCLUSIONS: In this small series, we found this approach sufficiently durable to continue its use for patients with acetabular metastases with collapse or those not responding to nonoperative measures. However, comparison studies are needed to determine whether it is superior or inferior to other available alternatives. LEVEL OF EVIDENCE: Level IV, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Rowell P, Lowe M, Sommerville S, et al. Is an Acetabular Cage and Cement Fixation Sufficiently Durable for the Treatment of Destructive Acetabular Metastases? Clin Orthop Relat Res. 2019. PMID: 31094843. doi:10.1097/CORR.0000000000000725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。